Polymer Capital Management (HK)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.2M Sell
27,000
-29,607
-52% -$34.9M 2.96% 5
2026
Q2
$67.9M Buy
56,607
+13,172
+30% +$13.5M 3.44% 4
2026
Q1
$40M Sell
43,435
-2,375
-5% -$2.41M 3.45% 5
2025
Q4
$49.2M Sell
45,810
-2,105
-4% -$2.01M 7% 2
2025
Q3
$36.6M Buy
47,915
+29,221
+156% +$21.7M 5.04% 2
2025
Q2
$14.6M Buy
18,694
+13,166
+238% +$10.2M 2.2% 12
2025
Q1
$4.57M Buy
5,528
+570
+11% +$474K 0.78% 40
2024
Q4
$3.83M Buy
4,958
+4,458
+892% +$3.69M 0.66% 44
2024
Q3
$443K Buy
+500
New +$450K 0.1% 117

Other funds holding LLY

Polymer Capital Management (HK)'s LLY Position: Q3 2026 in Review

Polymer Capital Management (HK) reduced its Eli Lilly (LLY) stake by 52% in Q3 2026, selling an estimated $34.9M and leaving 27,000 shares worth $31.2M. The position accounts for 2.96% of the portfolio, ranked #5.

Polymer Capital Management (HK) first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. The position peaked at $67.9M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Polymer Capital Management (HK) held 27,000 shares of Eli Lilly worth $31.2M as of Q3 2026.
  • Polymer Capital Management (HK) sold 29,607 Eli Lilly shares in Q3 2026, an estimated $34.9M.
  • Eli Lilly made up 2.96% of Polymer Capital Management (HK)'s portfolio in Q3 2026, its #5 holding.
  • Polymer Capital Management (HK) first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
  • Polymer Capital Management (HK)'s Eli Lilly position peaked at $67.9M in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Polymer Capital Management (HK)'s 13F filing for Q3 2026, filed 13 Nov 2026.